# O-GlcNAcylation of YAP1 promotes lung transplant ischemia-reperfusion injury via binding to HIF1α transcription factor and activating autophagy and mitophagy

**Authors:** Shaohua Dai, Xuemei Wan, Lingchun Xia, Lei Xu, Chunfan Xie, Guohui Wang, Jian Tang

PMC · DOI: 10.1038/s41419-026-08548-w · Cell Death & Disease · 2026-03-15

## TL;DR

This study shows that O-GlcNAcylation of YAP1 worsens lung transplant injury by boosting autophagy and mitophagy through HIF1α interaction.

## Contribution

The novel finding is that O-GlcNAcylation of YAP1 promotes lung transplant injury via HIF1α binding and autophagy activation.

## Key findings

- YAP1 O-GlcNAcylation enhances HIF1α binding and activates autophagy and mitophagy during lung injury.
- Knockdown of YAP1 or OGT reduces autophagy and tissue damage in lung transplant ischemia-reperfusion.
- O-GlcNAcylation of YAP1 is a key driver of lung epithelial cell stress and injury in transplantation.

## Abstract

Lung transplant ischemia-reperfusion injury poses a significant challenge in transplantation medicine, often causing severe complications and poor patient outcomes. Our study focused on the role of O-GlcNAcylation of Yes-associated protein 1 (YAP1) in exacerbating this injury by regulating autophagy and mitochondrial autophagy pathways. We found that hypoxia-reoxygenation robustly activated the Hippo-YAP1 signaling pathway, leading to increased damage in lung epithelial cells. Concurrently, autophagy and mitochondrial autophagy levels were significantly upregulated, indicating cellular stress responses. During actual lung transplantation, ischemia-reperfusion resulted in a marked increase in autophagy and mitochondrial autophagy levels, accompanied by elevated tissue damage. Notably, YAP1 played a crucial role in orchestrating these processes, as its knockdown reduced autophagy and mitochondrial autophagy levels under both hypoxia-reoxygenation and ischemia-reperfusion conditions. We further elucidated that OGT-mediated O-GlcNAc modification of YAP1 enhanced its interaction with HIF1α, activating downstream hypoxia-responsive molecules. Knockdown of the key enzyme OGT significantly mitigated autophagy, mitophagy, and associated damage in lung epithelial cells and transplant tissues subjected to hypoxia-reoxygenation and ischemia-reperfusion. These findings reveal the intricate interplay between O-GlcNAcylation of YAP1, HIF1α binding, autophagy activation, and mitochondrial autophagy in driving lung transplant ischemia-reperfusion injury, suggesting potential therapeutic targets for ameliorating its detrimental effects.

## Linked entities

- **Genes:** YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413], HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091], OGT (O-linked N-acetylglucosamine (GlcNAc) transferase) [NCBI Gene 8473]
- **Proteins:** HIF1A (hypoxia inducible factor 1 subunit alpha)

## Full-text entities

- **Genes:** YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413] {aka COB1, YAP, YAP-1, YAP2, YAP65, YKI}, CAT (catalase) [NCBI Gene 847], OGT (O-linked N-acetylglucosamine (GlcNAc) transferase) [NCBI Gene 8473] {aka HINCUT-1, HRNT1, MRX106, O-GLCNAC, OGT1, XLID106}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, Ccn2 (cellular communication network factor 2) [NCBI Gene 14219] {aka Ctgf, Fisp12, Hcs24, fisp-12}, CBLL2 (Cbl proto-oncogene like 2) [NCBI Gene 158506] {aka CT138, HAKAIL, ZNF645}, DNTT (DNA nucleotidylexotransferase) [NCBI Gene 1791] {aka TDT}, ARNT (aryl hydrocarbon receptor nuclear translocator) [NCBI Gene 405] {aka ARNT1, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, DAPK1 (death associated protein kinase 1) [NCBI Gene 1612] {aka DAPK, ROCO3}, Icam1 (intercellular adhesion molecule 1) [NCBI Gene 15894] {aka CD54, Icam-1, Ly-47, MALA-2}, OGA (O-GlcNAcase) [NCBI Gene 10724] {aka MEA5, MGEA5, NCOAT}, Hif1a (hypoxia inducible factor 1, alpha subunit) [NCBI Gene 15251] {aka HIF-1-alpha, HIF1-alpha, HIF1alpha, MOP1, bHLHe78}, MIR485 (microRNA 485) [NCBI Gene 574436] {aka MIRN485, hsa-mir-485, mir-485}, FUNDC1 (FUN14 domain containing 1) [NCBI Gene 139341], Areg (amphiregulin) [NCBI Gene 11839] {aka AR, Mcub, Sdgf}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, PINK1 (PTEN induced kinase 1) [NCBI Gene 65018] {aka BRPK, PARK6}, Ogt (O-linked N-acetylglucosamine (GlcNAc) transferase (UDP-N-acetylglucosamine:polypeptide-N-acetylglucosaminyl transferase)) [NCBI Gene 108155] {aka 1110038P24Rik, 4831420N21Rik, Ogtl}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, HMGB1 (high mobility group box 1) [NCBI Gene 3146] {aka HMG-1, HMG1, HMG3, SBP-1}, Yap1 (yes-associated protein 1) [NCBI Gene 22601] {aka Yap, Yap65, Yki, Yorkie}, PRKN (parkin RBR E3 ubiquitin protein ligase) [NCBI Gene 5071] {aka AR-JP, LPRS2, PARK2, PDJ}, NUMB (NUMB endocytic adaptor protein) [NCBI Gene 8650] {aka C14orf41, S171, c14_5527}, Ccn1 (cellular communication network factor 1) [NCBI Gene 16007] {aka Cyr61, Igfbp10}, TBK1 (TANK binding kinase 1) [NCBI Gene 29110] {aka AIARV, FTDALS4, IIAE8, NAK, T2K}, Birc5 (baculoviral IAP repeat-containing 5) [NCBI Gene 11799] {aka AAC-11, Api4, TIAP, survivin40}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, SAV1 (salvador family WW domain containing protein 1) [NCBI Gene 60485] {aka SAV, WW45, WWP4}, MAP1LC3B (microtubule associated protein 1 light chain 3 beta) [NCBI Gene 81631] {aka ATG8F, LC3B, MAP1A/1BLC3, MAP1LC3B-a}, MOB1A (MOB kinase activator 1A) [NCBI Gene 55233] {aka C2orf6, MABKL1B, MATS1, MOB1, MOBK1B, MOBKL1B}
- **Diseases:** necrosis (MESH:D009336), hypoxic (MESH:D002534), blood clotting (MESH:D013927), inflammation (MESH:D007249), hyperemia (MESH:D006940), interstitial edema (MESH:D004487), ischemic (MESH:D002545), cancer (MESH:D009369), tissue damage (MESH:D017695), fibrosis (MESH:D005355), H/R (MESH:D000860), Lung Injury (MESH:D055370), H (MESH:D000848), inflammatory cytokines (MESH:D000080424), lung (MESH:D008171), cold ischemia (MESH:D007511), PGD (MESH:D055031), IR injury (MESH:D015427), hemorrhage (MESH:D006470), I/R injury (MESH:C580424), transplant (MESH:D007674), end-stage lung diseases (MESH:D058625)
- **Chemicals:** CO2 (MESH:D002245), Hematoxylin (MESH:D006416), hydrochloric acid (MESH:D006851), chloroquine (MESH:D002738), glutaraldehyde (MESH:D005976), N2 (MESH:D009584), glucose (MESH:D005947), bicinchoninic acid (MESH:C047117), water (MESH:D014867), osmium tetroxide (MESH:D009993), fluorescein (MESH:D019793), Mito-Tracker Red CMXRos (MESH:C107472), epoxy (MESH:D004853), paraffin (MESH:D010232), formaldehyde (MESH:D005557), GlcNAc (MESH:D000117), PBS (MESH:D007854), HE (MESH:D006371), paraformaldehyde (MESH:C003043), Heparin (MESH:D006493), AP (MESH:D000667), alcohol (MESH:D000438), eosin (MESH:D004801), uranium acetate (MESH:C005460), xylene (MESH:D014992), TRIzol (MESH:C411644), Alexa Fluor 488 (MESH:C000711379), agarose (MESH:D012685), DMEM/F12 medium (-), H (MESH:D006859), polyvinylidene fluoride (MESH:C024865), Lipofectamine (MESH:C086724), Triton X-100 (MESH:D017830), ethanol (MESH:D000431), O2 (MESH:D010100), hydroxychloroquine (MESH:D006886), dUTP (MESH:C027078), pentobarbital sodium (MESH:D010424)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** shOGT-2 — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_A628), HEK293A — Homo sapiens (Human), Transformed cell line (CVCL_0045), shOGT-1 — Mus musculus (Mouse), Hybridoma (CVCL_C7RB), shYAP1-2 — Rattus norvegicus (Rat), Adenocarcinoma of the rat prostate, Cancer cell line (CVCL_3569)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13039928/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13039928/full.md

---
Source: https://tomesphere.com/paper/PMC13039928